SCHEMBL5455934

SCHEMBL5455934

CC(C)(C)OC(=O)N1CCN(c2ccc(NC(=O)Nc3ccccc3Oc3ccccc3)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.58
MAPT P10636 6/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.51
MEN1 O00255 2/20 0.51
TSHR P16473 2/20 0.51
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 4/20 0.51
ESR2 Q92731 1/20 0.51
P2RY1 P47900 4/20 0.50
GPR119 Q8TDV5 1/20 0.50
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
LMNA P02545 3/20 0.49
NR2F2 P24468 2/20 0.49
HTT P42858 2/20 0.49
KDM4E B2RXH2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5460919 0.89 NAMPT (0.53) NAMPTMAPTNPC1SMN1; SMN2MEN1
SCHEMBL5460804 0.89 MAPT (0.68) NAMPTMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL5466989 0.87 NAMPT (0.59) NAMPTMAPTNPC1SMN1; SMN2MEN1
SCHEMBL5462055 0.86 NAMPT (0.58) NAMPTMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL5465589 0.86 NAMPT (0.58) NAMPTMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL5460905 0.85 NAMPT (0.57) NAMPTMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL5457972 0.85 NAMPT (0.64) NAMPTMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL5464907 0.84 NAMPT (0.62) NAMPTMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL5457840 0.84 NAMPT (0.62) NAMPTMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL5458260 0.83 NAMPT (0.61) NAMPTMAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 NAMPT 324/4885MAPT 758/4885NPC1 1089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.